Clinical Trial

SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer

Name: SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer — clinical trial record (NCT07697586)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open-label, multi-center, Phase II clinical study to evaluate the safety, tolerability, and efficacy of SKB264 in combination with SKB118 in participants with NSCLC. The study includes a dose escalation phase and an expansion phase.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-13

Trial Details

NCT Number	NCT07697586
Lead Sponsor	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Conditions	NSCLC
Enrollment	206 participants
Start Date	2026-08-07
Primary Completion	2028-08 (estimated)
Study Completion	2029-08 (estimated)
Updated on ClinicalTrials.gov	2026-08-12